# Lisdexamfetamine dimesylate

NDC: 0781-2476
Generic name: Lisdexamfetamine dimesylate
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250916

FDA application: ANDA202836

## Active ingredients

- LISDEXAMFETAMINE DIMESYLATE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0781-2476"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0781-2476
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=808cce3b-eee8-4f58-8d8a-53a4ce79ae7c